DESIGN, FORMULATION AND EVALUATION OF TRANSDERMAL DRUG DELIVERY SYSTEM OF BUDESONIDE

被引:0
|
作者
Amgaokar, Yogesh M. [1 ]
Chikhale, Rupesh V. [1 ]
Lade, Updesh B. [1 ]
Biyani, Dinesh M. [1 ]
Umekar, Milind J. [1 ]
机构
[1] Smt Kishoritai Bhoyar Coll Pharm, Dept Pharmaceut, Nagpur, MS, India
关键词
Transdermal drug delivery; Budesonide; corticosteroid; IN-VIVO EVALUATION; PHARMACOLOGICAL-PROPERTIES; THERAPEUTIC-EFFICACY; VITRO; PROPRANOLOL; DICLOFENAC; RHINITIS;
D O I
暂无
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Budesonide is a highly potent synthetic, nonhalogenated corticosteroid. The mechanism of action of corticosteroids in allergic rhinitis remains unknown, but may involve reductions in number of various mediator cells such as basophils, eosinophils, T-helper cells, mast cells, and neutrophils. In the nasal mucosa, nasal reactivity to allergens, and release of inflammatory mediators and proteolytic enzymes. Budesonide is very effective and quikly acting as it is rapidly and almost completely absorbed after oral administration, but has poor systemic availability (about 10%) due to extensive first-pass metabolism in the liver, mainly by the cytochrome P450 isoenzyme CYP3A4.. The major metabolites, 6-beta-hydroxybudesonide and 16-alpha-hydroxyprednisolone have less than 1% of the glucocorticoid activity of unchanged drug with a terminal half-life of about 2-4 hours. Polymeric films containing Eudragit RL 100: Eudragit RS: drug (7:3:1, 7:2:1) and Ethyl cellulose: PVP: drug (7:3:1, 7:2:1) were selected for transdermal administration based on evaluation studies. These polymeric films were prepared by mercury substrate method employing PEG-400 as plasticizer. Two different penetration enhancers Urea and Dimethyl sulphoxide (DMSO) were employed in the study. The patches in each group were uniform in drug content, thickness. In Vitro drug permeation, moisture absorption and WVTR studies were carried out on these test patches. It was found that at all humidity condition the absorption increases which were linear to the moisture absorbed. In PVA and EUDRAGIT RL 100 patches the water vapor transmission rate was found to be higher at 75% RH, RT conditions. Therefore at both % RH, RT condition the PVA and EUDRAGIT RL 100 patches provides the best resistance to water vapor. Therefore, when applied to animals (in further studies) these patches may provide more occlusion to water vapor loss from skin thus making atmosphere beneath the skin more humid that aid in drug permeation.
引用
收藏
页码:475 / 497
页数:23
相关论文
共 50 条
  • [22] Formulation, Optimization, and In vivo Evaluation of Clozapine Loaded Transdermal Drug Delivery System for the Treatment of Schizophrenia
    Agrawal, Milan B.
    Patel, Mayur M.
    [J]. ASIAN JOURNAL OF PHARMACEUTICS, 2020, 14 (04) : 556 - 571
  • [23] Design and evaluation of a lorazepam transdermal delivery system
    Costa, P
    Ferreira, DC
    Morgado, R
    Lobo, JMS
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1997, 23 (10) : 939 - 944
  • [24] Formulation and Evaluation of a Drug-in-Adhesive Patch for Transdermal Delivery of Colchicine
    Lei, Yaran
    Yang, Guobao
    Du, Feng
    Yi, Jiahe
    Quan, Liangzhu
    Liu, Hanhan
    Zhou, Xun
    Gong, Wei
    Han, Jing
    Wang, Yuli
    Gao, Chunsheng
    [J]. PHARMACEUTICS, 2022, 14 (10)
  • [25] Design of a transdermal delivery system for aspirin as an antithrombotic drug
    Ammar, H. O.
    Ghorab, M.
    El-Nahhas, S. A.
    Kamel, R.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 327 (1-2) : 81 - 88
  • [26] Design of a smart transdermal insulin drug delivery system
    Hou, Zhenqing
    Lin, Chenghong
    Zhang, Qiqing
    [J]. 2010 4TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL ENGINEERING (ICBBE 2010), 2010,
  • [27] Influence of formulation variables in transdermal drug delivery system containing zolmitriptan
    Subedi, Robhash Kusam
    Ryoo, Je-Phil
    Moon, Cheol
    Choi, Hoo-Kyun
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 419 (1-2) : 209 - 214
  • [28] DESIGN, DEVELOPMENT AND EVALUATION OF TRANSDERMAL DRUG DELIVERY OF CAPTOPRIL, AN ANTIHYPERTENSIVE DRUG
    Khaja, Md.
    Syed, Muneer
    Rao, D. Srinivasa
    [J]. INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 1 (05): : 305 - 314
  • [29] Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride
    Akram, Muhammad Rouf
    Ahmad, Mahmood
    Abrar, Asad
    Sarfraz, Rai Muhammad
    Mahmood, Asif
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 349 - 364
  • [30] Importance of chronopharmacokinetics in design and evaluation of transdermal drug delivery systems
    Gries, JM
    Benowitz, NL
    Verotta, D
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PI63 - PI63